Mono-POC Ethyl Tenofovir
| Product Name | Mono-POC Ethyl Tenofovir |
|---|---|
| Alternate Names | Tenofovir Impurities, Impurities of Tenofovir |
| CAT No. | CS-O-11174 |
| CAS No. | 1796539-92-8 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 431.38 g/mol |
| Mol. For. | C16H26N5O7P |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Tenofovir |
| Purity | Not less than 90 % |
| Therapeutic | Antiretroviral / Anti-HIV |
| Smileys | C[C@@H](OC[P](OCOC(OC(C)C)=O)(OCC)=O)CN1C2=NC=NC(N)=C2N=C1 |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Mono-POC Ethyl Tenofovir is a novel prodrug of Tenofovir, which is used in the treatment of HIV and Hepatitis B virus infections. It is a nucleotide analog reverse transcriptase inhibitor that works by blocking the replication of the virus. Mono-POC Ethyl Tenofovir is designed to improve the bioavailability and pharmacokinetics of Tenofovir, thereby reducing the frequency of dosing and minimizing adverse effects.
The chemical structure of Mono-POC Ethyl Tenofovir consists of a phosphonamidate prodrug linked to a lipophilic ethyl group. The lipophilic nature of this compound allows for increased cellular uptake and better distribution into the target cells. The prodrug is selectively activated by esterases in the plasma and liver, releasing the active form of Tenofovir.
Mono-POC Ethyl Tenofovir is administered orally and has been studied in clinical trials for its safety and efficacy. It has shown promising results in reducing viral load and improving immune function in HIV-infected patients. Additionally, it has been found to be effective in the treatment of chronic Hepatitis B infections.
In conclusion, Mono-POC Ethyl Tenofovir is a prodrug of Tenofovir that has been designed to improve its bioavailability and pharmacokinetics. It has shown promising results in the treatment of HIV and Hepatitis B virus infections and may offer a safer and more effective alternative to current therapies.
Get an Instant Quote
Related Compounds
Mono-POC Isopropyl Tenofovir | Tenofovir disoproxil impurity L | Tenofovir Alafenamide Dimer impurity | Mono-POC Methyl Tenofovir Fumarate (Mixture of Diastereomers) | Tenofovir Disoproxil Fumarate Impurity | Tenofovir disoproxil impurity L fumarate | Mono ester impurity (Tenofovir) | Isopropyl Tenofovir | Tenofovir alafenamide lactose Millard Reaction product-3 | TAF SRS diastereomer | Tenofovir EP Impurity C Succinate | Mono poc-isopropyl-Tenofovir fumarate salt | Tenofovir Impurity 89 | Tenofovir Impurity 35 | Tenofovir Alafenamide Glycosamine product | MOC-POC Tenofovir | Ethyl Tenofovir Impurity | Tenofovir Disoproxil T7 Impurity | Tenofovir Disoproxil Fumarate USP RC J | TenofovirDisoproxil Ethyl fumarate Impurity | Tenofovir alafenamide lactose Millard Reaction product-2 | Tenofovir alafenamide Impurity 2 | Tenofovir Impurity 62 | Tri-POC Tenofovir Dimer | Tenofovir Diphenyl HemiFumarate salt | Tenofovir Alanine ester impurity | Tenofovir impurity C fumarate salt | Tenofovir DP-V | Tenofovir disoproxil phosphate | Tenofovir Disoproxil T8 Impurity | nPOC-POC Tenofovir Fumarate | Tenofovir Disoproxil (S)-Isomer fumarate salt | Tenofovir diphosphate | Desmethyl Tenofovir disoproxil | Diisopropyl Tenofovir Fumarate | Tenofovir Alfenamide Amadori Rearrangement product | Tenofovir Impurity 36 (RSR) 2,3-dihydroxysuccinate salt | Tenofovir Disoproxil T11 Impurity | Tenofovir alafenamide Impurity 1 | Tenofovir Alafenamide (RSR) Diasteroisomer | Tenofovir alafenamide Methyl ester impurity | Tenofovir Mono-POC methyl ester | Tenofovir Alafenamide N-hydroxy methyl impurity | Tenofovir Isopropyl Carbamate | Tenofovir Impurity 39 (RRR) 2,3-dihydroxysuccinate salt | MOC-POC Tenofovir Fumarate | Tenofovir Mono POC Dimer Diethyl amine salt | Diethylaminocarboxymethyl POC Tenofovir Fumarate | Tenofovir Impurity 65 | TAF methyl ester | Tenofovir Disoproxil T5 Impurity | Tenofovir Alafenamide Enantiomer | Tenofovir isomer 6&1 | Tenofovir Disoproxil Isopropoxycarbonyl | Tenofovir Impurity 59-D6 | Tenofovir Alafenamide fumarate | Tenofovir Impurity 59 | Tenofovir alafenamide (RRS) diasteroisomer | Desmethyl Tenofovir Disoproxil Fumarate | Tenofovir alafenamide monofumarate | Tenofovir Alafenamide Racemic D Isomer | Tenofovir Disoproxil T12 Impurity | Tenofovir Related Compound 14 | Tenofovir Bis ((R)-9-(2-Hydroxypropyl)adenine) dimer Acetate salt | Tenofovir alafenamide Impurity 5 | Tenofovir Alafenamide Dimer Impurity II | Tenofovir Related Compound 5 | Mono-POC Tenofovir 6-Isopropyl Carbamate | TAF Propyl ester Impurity | Diethylaminocarboxymethyl POC Tenofovir (Mixture of Diastereomers) |